Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 52,699 shares at $96.00 ($5.1M) on 2025-08-13, disclosed to the SEC on 2025-08-14.
Scheduled sale ($5.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.33 | 24,611 | $2.4M | 46.7% |
| 2 | $96.33 | 24,611 | $2.4M | 46.7% |
| 3 | $96.00 | 3,477 | $334K | 6.6% |
| Total | $96.31 avg | 52,699 | $5.1M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-07-11 | $4.8M | — | Filing → |